EPHX2 and Insulin resistance: In line with the effects of sEH gene knockout, administration of EET analogues reduced hepatic fibrosis, insulin resistance, and inflammation induced by HFD, which is associated with an increase in HO-1-PGC1α and enhanced insulin receptor phosphorylation [147].